SignaBlok, Inc.

P.O. Box 4064
Shrewsbury, Massachusetts

Booth: 928

Showcase presenter


Targeted theranostics for diagnostic imaging and treatment

Technology Area: Pharmaceuticals & Personal Care

Commercial Maturity: Proven Manufacturability

Abstract: Inflammation-associated diseases such as atherosclerosis and cancer are leading causes of death worldwide. SignaBlok’s nanotechnology provides the most natural way to deliver imaging probes and therapies to macrophages, inflammatory cells that are critically involved in these disorders. This could substantially improve early diagnosis and treatment of these disorders.